【24h】

Embedded drug delivery controller for cancer chemotherapy under treatment constrains

机译:在治疗限制下用于癌症化疗的嵌入式药物输送控制器

获取原文
获取原文并翻译 | 示例

摘要

Chemotherapy is one of the essential treatment methods for cancer patients. This paper presents a new embedded fuzzy logic control scheme of cancer chemotherapy drug delivery system. The developed controller is capable of achieving targeted drug concentrations at tumor tissues to minimize number of cancerous cells, considering therapeutic constraints; namely maximum allowed levels of both drug infusion dose and drug-dose toxicity. This study has been successfully validated using hardware-in-the-loop simulation technique, based on a mathematical model of patient chemotherapy response and Arduino Mega microcontrollers. Compared to previous studies, the results of embedded drug infusion controller showed that the smallest value of remaining cancerous cells is 8.34, the toxic level of injected drug does not exceed the maximum value of clinical constraint at 100 mg/ml/day, and the best performance index of cancer chemotherapy is 25.51 at the end of treatment time. Therefore, the embedded closed-loop controller in this study presents potentially a good upgrade option for clinical drug delivery systems to enhance the performance of intravenous cancer chemotherapy procedures.
机译:化学疗法是癌症患者的基本治疗方法之一。本文提出了一种新型的嵌入式化疗药物嵌入式模糊逻辑控制方案。考虑到治疗方面的限制,开发的控制器能够在肿瘤组织上达到目标药物浓度,从而将癌细胞的数量降至最低。即输注剂量和药物剂量毒性的最大允许水平。基于患者化疗反应和Arduino Mega微控制器的数学模型,已使用硬件在环仿真技术成功验证了此研究。与以前的研究相比,嵌入式药物输注控制器的结果表明,残留癌细胞的最小值为8.34,注射药物的毒性水平未超过100 mg / ml / day的临床约束最大值,最佳在治疗结束时,癌症化学治疗的性能指数为25.51。因此,本研究中的嵌入式闭环控制器为临床药物输送系统提供了很好的升级选项,以增强静脉癌化疗程序的性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号